PharmaDerm is a specialty pharmaceutical company dedicated to developing and commercializing prescription products to treat diseases and conditions of the skin—the largest organ of the human body. Our goal is to pursue development of products that will help improve the lives of patients with skin disease.
Our growing portfolio of products provide effective prescription therapies for the treatment of a variety of skin diseases including acne, actinic keratosis (AK), eczema, external genital warts, fungal disease, psoriasis and rosacea.
PharmaDerm, combined with Fougera, is the number one manufacturer of topical pharmaceutical products in the United States. Over the last 8 years, we have developed over 60 FDA-approved topical therapies in the United States—more than any other company in that time frame.
PharmaDerm is uniquely positioned as a fully vertically-integrated specialty pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, sales and marketing.